Recipient
Showing 26 - 50 of 2,701
End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])
Withdrawn
- End Stage Renal Disease
- Chronic Hepatitis c
- Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
-
Boston, MassachusettsMassachusetts General Hospital
Mar 4, 2022
Atrophic Anterior Alveolar Ridge Trial in Mansoura (harvesting bone block, Recipient site preparation, implant insertion)
Completed
- Atrophic Anterior Alveolar Ridge
- harvesting bone block
- +2 more
-
Mansoura, Eldakahlia, EgyptFaculty of Dentistry, Mansoura University
Apr 25, 2023
Graft Loss, Condition Trial in Basel, Zuerich (pre-expansion using Kiwi® VAC-6000M., pre-heating using Hilotherm Calido®.,
Recruiting
- Graft Loss
- Condition
- pre-expansion using Kiwi® VAC-6000M.
- +2 more
-
Basel, Switzerland
- +1 more
Jan 18, 2022
Healthy Trial in Halifax (Meningococcal B, High-Dose TIV, Tdap (tetanus-diphtheria-acellular pertussis))
Completed
- Healthy
- Meningococcal B
- +5 more
-
Halifax, Nova Scotia, CanadaIWK Health Centre
Mar 10, 2022
Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney
Recruiting
- type1diabetes
- +2 more
- Pancreatic islet transplantation after kidney transplantation
-
Lille, FranceHop Claude Huriez Chu Lille
Dec 21, 2022
Long-Term Follow-Up of Recipient of Gene Transfer Research
Recruiting
- Retroviridae Infections
- Cancer
- Blood Tests
- Questionnaires
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 22, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +3 more
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
-
Columbus, Ohio
- +1 more
Apr 20, 2022
Donor-recipient ABO Matching on Haploidentical Stem Cell
Completed
- Hematological Malignancies
- Haploidentical Stem Cell Transplantation
- no intervention
-
Hangzhou, Zhejiang, China
- +1 more
Oct 22, 2021
Kidney Transplant Recipient Response to Shingrix Vaccine Trial (Shingrix)
Not yet recruiting
- Kidney Transplant Recipient Response to Shingrix Vaccine
- Shingrix
- (no location specified)
Mar 17, 2022
Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell
Completed
- Term and Preterm Neonates (24-41 Weeks Gestational Age)
- Hematopoietic Stem Cell Transplant Recipient Children
- Tubes fund recovery blood count
- the rest of the blood test and stool sample
-
Paris, FranceHôpital Robert Debré
Feb 2, 2023
University of Minnesota Transplant Registry
Recruiting
- Transplant Recipient
- Transplant Donation
-
Minneapolis, MinnesotaUniversity of Minnesota Transplant Information Services
Mar 25, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023
Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy
Active, not recruiting
- Kidney Transplant Rejection
- +2 more
- Kidney allograft biopsy depending on donor-derived cell-free DNA levels
-
Berlin, GermanyCharité-Universitätsmedizin
Jul 22, 2022
Hearing Loss Trial in Melbourne (Cochlear implant with in-situ audiometry)
Completed
- Hearing Loss
- Cochlear implant with in-situ audiometry
-
Melbourne, Victoria, AustraliaThe HEARing CRC
Jul 2, 2021
Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of Trial in San Diego (glecaprevir/pibrentasvir (GLE/PIB))
Completed
- Hepatitis C
- Hepatitis C Virus Infection, Response to Therapy of
- glecaprevir/pibrentasvir (GLE/PIB)
-
San Diego, CaliforniaUniversity of California San Diego
May 23, 2022
Graft Function in Adult Egyptian Patients Undergoing Living
Completed
- Donor to Recipient Gender Mismatch in LDLT
- non interventional
-
Cairo, Ain Shams University Specialized Hospital, EgyptHanaa El Gendy
Feb 15, 2022
Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto
Completed
- Myelodysplastic/Myeloproliferative Neoplasm
- +2 more
- Decidual stromal cells (DSC)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))
Active, not recruiting
- Lung Transplant Recipient
- +2 more
- mRNA-1273 (Moderna COVID-19 vaccine)
-
Los Angeles, CaliforniaUCLA Clinical Translational Research Center
Dec 13, 2022
Opioid Use, Unspecified Trial in Chicago (Opioid naive, At-risk for long term use, Long-term opioid recipient)
Completed
- Opioid Use, Unspecified
- Opioid naive
- +2 more
-
Chicago, IllinoisNorthwestern University
Jul 21, 2022
Renal Transplantation Trial in Petah-Tikva (Combined kidney and bone marrow transplantation)
Recruiting
- Renal Transplantation
- Combined kidney and bone marrow transplantation
-
Petah-Tikva, IsraelRabin Medical Center
Oct 20, 2021
Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow
Available
- Benign Neoplasm
- +3 more
- Bone Marrow Transplantation
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 9, 2021
Absolute Uterine Factor Infertility Trial in Göteborg, Gothenburg (Robotic surgery)
Recruiting
- Absolute Uterine Factor Infertility
- Robotic surgery
-
Göteborg, None Selected, Sweden
- +1 more
Dec 14, 2021
REnal TRansplant Outcomes After CARdiac Surgery (RETROCAR)
Completed
- Cardiac Surgery
- +2 more
- standard of care
-
Pessac, FranceBordeaux University Hospital
Dec 8, 2021
Liver Transplant Disorder Trial (regional analgesia)
Not yet recruiting
- Liver Transplant Disorder
- regional analgesia
- (no location specified)
Apr 6, 2021